| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8684357 | European Journal of Paediatric Neurology | 2018 | 24 Pages |
Abstract
The main effect of cyclophosphamide combination therapy on neuroinflammation in OMS was moderate reduction in CSF B cell expansion. Though exploratory, it may provide a steroid sparer option in partially-responsive OMS.
Keywords
Related Topics
Life Sciences
Neuroscience
Developmental Neuroscience
Authors
Michael R. Pranzatelli, Tyler J. Allison, Elizabeth D. Tate,